A highly vancomycin-resistant laboratory mutant of Staphylococcus aureus

FEMS Microbiology Letters

Volumn 142, Issue 2-3, 1996, Pages 161-166

  Sieradzki, Krzysztof ^a   Tomasz, Alexander ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Staphylococcus aureus; Vancomycin resistance

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BACTERIUM MUTANT; BIOCHEMISTRY; CONTROLLED STUDY; ENTEROCOCCUS; LEUCONOSTOC; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0030246884     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-1097(96)00259-5     Document Type: Article

References (15)

1. [1] Schwalbe, R.S., Stapleton, J.T. and Gilligan, P.H. (1987) Emergence of vancomycin resistance in coagulase-negative staphylococci. New Engl. J. Med. 316, 927-931.
2. [2] Veach, L.A., Pfaller, M.A., Barrett, M., Koontz, F.P. and Wenzel, R.P. (1990) Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J. Clin. Microbiol. 28, 2064-2068.
3. [3] Biavasco, F., Giovanetti, E., Montanari, M.P., Lupidi, R. and Varaldo, P.E. (1991) Development of in vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species. J. Antimicrob. Chemother. 27, 71-79.
4. [4] Daum, R.S., Gupta, S., Sabbagh, R. and Milewski, W.M. (1992) Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J. Infect, Dis. 166, 1066-1072.
5. +-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40, 166-172.
6. [6] Woodford, N., Johnson, A.P., Morrison, D. and Speller, D.C.E. (1995) Current perspectives on glycopeptide resistance. Clin. Microbiol. Rev. 8, 585-615.
7. [7] Tomasz, A., Nachman, S. and Leaf, H. (1991) Stable classes of phenotypic expression in methicillin resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 35, 124-129.
8. [8] Hartman, B.J. and Tomasz, A, (1986) Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 29, 85-92.
9. [9] De Jonge, B.L.M., de Lencastre, H. and Tomasz, A. (1991) Suppression of autolysis and cell wall turnover in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain. J. Bacteriol., 173, 1105-1110.
10. [10] De Jonge, B.L.M., Chang, Y.-S., Gage, D. and Tomasz, A. (1992) Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain: the role of penicillin binding protein 2A. J. Biol. Chem. 267, 11248-11254.
11. [11] Flouret, B., Mengin-Lecreulx, D. and van Heijenoort, J. (1981) Reverse-phase high-pressure liquid chromatography of uridine diphosphate N-acetylmuramyl peptide precursors of bacterial cell wall peptidogylcan. Anal. Biochem. 114, 59-63.
12. [12] Inman, E.L. (1987) Determination of vancomycin related substances by gradient high-performance liquid chromatography. J. Chromatogr. 410, 363-372.
13. [13] Severin, A. and Tomasz, A. (1996) Naturally occurring peptidoglycan variants of Streptococcus pneumoniae. J. Bacteriol. 178, 168-174.
14. [14] De Jonge, B.L.M., Handwerger S. and Gage, D. (1996) Altered peptidoglycan composition in vancomycin-resistant Enterococcus faecium. Antimcirob. Agents Chemother. 40, 863-869.
15. [15] De Jonge, B.L.M., Gage, D. and Handwerger, S. (1996) Peptidoglycan composition of vancomycin-resistant Enterococcus faecium. Microbial Drug Resist. 2, in press.